Skip to main content

IRB Committee 1

IRB Committee 1 is responsible for the full review of human subjects research protocols submitted by faculty/staff for:

  • Health & Human Performance (HHP) Department of CLASS
  • College of Education
  • College of Medicine
  • College of Natural Sciences & Mathematics
  • College of Nursing
  • College of Optometry
  • College of Pharmacy
  • College of Technology
  • Cullen College of Engineering
All FDA-regulated research is also reviewed by IRB 1, regardless of college.

Full Committee

Submission Deadlines IRB 1 Meeting Dates
Friday, August 4, 2023 Friday, August 18, 2023
Friday, September 01, 2023 Friday, September 15, 2023 
Friday, October 06, 2023 Friday, October 20, 2023 
Friday, November 03, 2022 Friday, November 17, 2023
Wednesday, November 24, 2023 Friday, December 8, 2023
Friday, January 05, 2024 Friday, January 19, 2024
Friday, February 02, 2024 Friday, February 16, 2024
Friday, March 08, 2024 Friday, March 22, 2024
Friday, April 05, 2024 Friday, April 19, 2024
Friday, May 03, 2024 Friday, May 17, 2024
Friday, June 07, 2024 Friday, June 21, 2024
Friday, July 05, 2024 Friday, July 19, 2024
Friday, August 2, 2024 Friday, August 16, 2024

*Dates are subject to change without notice if circumstances require rescheduling.

Expedited Review 

Protocols falling under an expedited category and involving no more than minimal risk, as well as minor changes in approved full board protocols, may be reviewed under an expedited process. The Chair of IRB 1 either reviews or delegates the review to one or more experienced IRB members, who review the protocol under applicable regulations and either approve or require modifications to the protocol prior to approval. An expedited reviewer may not disapprove a protocol, but may forward to the fully convened committee for further determination if warranted. Expedited submissions are considered on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.  

Exempt Status

Protocols falling under an exempt category defined under the federal regulations require administrative review by the IRB office to ensure that basic ethical principles, such as confidentiality of data and obtaining informed consent where applicable, are addressed. Applications for exempt protocols are reviewed by IRB staff on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.